Moderna reported $575M in Loan Capital for its fiscal quarter ending in December of 2023.

Loan Capital Change Date
Acadia Pharmaceuticals USD 0 0 Jun/2022
Adcock Ingram Holdings ZAR 279.98M 17.16M Jun/2023
Agios Pharmaceuticals USD 1.06M 0 Sep/2022
Cspc Pharmaceutical CNY 107.06M 99.73M Dec/2023
Gilead Sciences USD 23.19B 1.98B Sep/2023
Kangmei Pharma CNY 195.86M 3.82M Sep/2023
Knight Therapeutics CAD 54.49M 1.67M Sep/2023
Laboratorios Farma EUR 54.54M 4.9M Jun/2023
Magenta Therapeutics USD 0 0 Jun/2022
Malin Corporation EUR 0 0 Dec/2021
Organigram Holdings CAD 100K 18K Mar/2023
Pharma Mar EUR 28.82M 234K Sep/2023
Sartorius EUR 5.04B 2.76B Sep/2023
Sino Biopharmaceutical CNY 1.03B 3.23B Jun/2023
Ultragenyx Pharmaceutical USD 0 0 Jun/2022
Zz Pientze Pharmaceu 126.63M 8.63M Sep/2023